首页> 美国卫生研究院文献>other >MEDICAL vs. MEDICAL AND SURGICAL TREATMENT FOR BRUCELLA ENDOCARDITIS: A REVIEW OF THE LITERATURE
【2h】

MEDICAL vs. MEDICAL AND SURGICAL TREATMENT FOR BRUCELLA ENDOCARDITIS: A REVIEW OF THE LITERATURE

机译:医疗与医疗和手术治疗布鲁氏菌性心内膜炎:对文献的回顾

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This review was undertaken to determine the role of surgery in the treatment of brucella endocarditis. All English and French articles reporting brucella endocarditis (1966–2011) in Pubmed, Google and Scopus were reviewed. 308 cases were identified and Linear and Logistic regression was performed. Surgery improved outcomes by decreasing mortality from 32.7% in the medical treatment only group to 6.7% in the combined surgical and medical treatment group (p<.001). This association was still significant while controlling for other contributing factors. In the absence of a controlled trial, we recommend the utmost vigilance and consideration of surgical management in treating such patients.
机译:进行这项审查,以确定手术在布鲁氏菌性心内膜炎的治疗中的作用。审查了Pubmed,Google和Scopus上所有报告布鲁氏菌性心内膜炎(1966-2011)的英文和法文文章。确定了308例病例,并进行了线性和逻辑回归分析。手术通过将死亡率从仅药物治疗组的32.7%降低到手术和药物治疗联合组的6.7%(p <.001),改善了结局。在控制其他影响因素的同时,这种关联仍然很重要。在没有对照试验的情况下,我们建议在治疗此类患者时保持高度警惕并考虑手术管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号